In a move towards greater environmental responsibility in the life sciences sector, Greiner Bio-One has announced that its serological pipettes have been awarded the ACT (Accountability, Consistency and Transparency) ecolabel. This certification, granted by the non-profit organisation My Green Lab, represents a significant step in providing scientists and procurement specialists with verified information about the […]

Cancer Research UK has announced funding of up to £600,000 for a groundbreaking project aimed at developing the world’s first ovarian cancer prevention vaccine. The initiative, led by Professor Ahmed Ahmed at the University of Oxford, seeks to leverage recent advancements in immunology and cancer biology to create a vaccine that could potentially prevent ovarian […]

Paris-based AzurBio Pharma has officially launched, positioning itself as a strategic partner for biopharmaceutical companies seeking to bring innovative treatments to the European market. The company, founded by industry veteran Corinne Schmitz, aims to streamline the often complex process of European market entry, with a particular focus on rare and serious diseases with unmet medical […]

Norgine, a prominent European specialty pharmaceutical and consumer healthcare company, has announced a significant leadership change with the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective 1 January 2025. This move comes as part of the company’s strategy to enhance its mission of delivering transformative medicines to patients and […]